SHPH — Shuttle Pharmaceuticals Holdings, Inc.

Open full analysis

Chart, dilution, float and news for SHPH in the TickerWise workspace.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Company profile

• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic
• Country: US
• Exchange: NASDAQ Global Market
• Employees: 9
• Website: https://www.shuttlepharma.com

Latest SEC filings for SHPH

• 2026-09-2410-Q
• 2026-09-248-K/A
• 2026-09-168-K
• 2026-09-118-K
• 2026-09-028-K
• 2026-09-018-K
• 2026-08-288-K
• 2026-08-17NT 10-Q
• 2026-08-178-K/A
• 2026-07-133

Latest SHPH news

• 2026-10-02Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update Read article

Open full analysis

Educational tool only — not investment advice.